5 years ago

Novel Osmium-based Coordination Complexes as Photosensitizers for Panchromatic Photodynamic Therapy

Novel Osmium-based Coordination Complexes as Photosensitizers for Panchromatic Photodynamic Therapy
Savo Lazic, Pavel Kaspler, Lothar Lilge, Arkady Mandel, Kamola Kasimova, Sherri McFarland, Susan Monro, Ge Shi, Robie Hennigar, Sarah Forward, Tariq Sainuddin
Cancer remains a major global malaise requiring the advent of new, efficient and low-cost treatments. Photodynamic therapy, which combines a photosensitizer and photons to produce cytotoxic reactive oxygen species, has been established as an effective cancer treatment but has yet to become mainstream. One of the main limitations has been the paucity of photosensitizers that are effective over a wide range of wavelengths, can exert their cytotoxic effects in hypoxia, are easily synthesized and produce few if any side effects. To address these shortfalls, three new osmium-based photosensitizers (TLD1822, TLD1824 and TLD1829) were synthesized and their photophysical and photobiological attributes determined. These photosensitizers are panchromatic (i.e. black absorbers), activatable from 200 to 900 nm and have strong resistance to photobleaching. In vitro studies show photodynamic therapy efficacy with both red and near-infrared light in normoxic and hypoxic conditions, which translated to good in vivo efficacy of TLD1829 in a subcutaneous murine colon cancer model. Coordination complexes are gain rapidly attention as a central building block for photosensitizer in photodynamic Therapy. Initial coordination complexes Ruthenium-based photosensitizers are often limited in their ability to absorb light in the red spectral range. Using osmium as central photosensitizer alleviates this spectral limitation. Here, three different Os(II) constructs with π-extended 2,2′-biquinoline (biq) ligands, are investigated photochemical and photobiological, in vitro as well as in vivo. These studies identified [Os(biq)2(Imidazo[4,5-f][1,10]phenathroline)](PF6)2 as the preferred photosensitizer among the three tested, for further extended in vivo studies.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/php.12767

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.